Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy

NCT04299425 is registered in ClinicalTrials.gov with Vanderbilt-Ingram Cancer Center as lead sponsor.

NCT NCT04299425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04299425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy
Lead sponsor
Vanderbilt-Ingram Cancer Center
Phase
Not applicable
Overall status
Completed
Start date
March 13, 2020
Completion date
March 3, 2023
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypercalcemia, parathyroid adenoma, parathyroid cancer, parathyroid hyperplasia, parathyroid neoplasms, primary hyperparathyroidism